Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC

27th Apr 2021 14:21

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing26 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

1,740,139

1.35%

166,350

0.13%

 

(2)

Derivatives (other than options):

72,359

0.06%

7,134

0.01%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 
TOTAL:

1,818,598

1.41%

179,584

0.14%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit

Purchase

2

232.5900 USD

Purchase

2

232.4900 USD

Purchase

31

232.5100 USD

Purchase

40

231.6200 USD

Purchase

40

231.4900 USD

Purchase

50

234.2150 USD

Purchase

60

231.4850 USD

Purchase

60

232.2300 USD

Purchase

77

231.5968 USD

Purchase

100

232.7100 USD

Purchase

101

231.6953 USD

Purchase

140

232.5700 USD

Purchase

165

232.7838 USD

Purchase

200

232.2050 USD

Purchase

200

232.1780 USD

Purchase

200

231.5550 USD

Purchase

200

231.5250 USD

Purchase

200

231.2850 USD

Purchase

200

232.2950 USD

Purchase

220

231.5422 USD

Purchase

234

231.2841 USD

Purchase

300

233.0666 USD

Purchase

300

232.3800 USD

Purchase

301

232.3249 USD

Purchase

400

234.2550 USD

Purchase

400

233.6025 USD

Purchase

400

231.7104 USD

Purchase

476

231.4888 USD

Purchase

500

231.5860 USD

Purchase

1,182

231.5395 USD

Purchase

1,267

232.5279 USD

Purchase

1,799

231.9742 USD

Purchase

1,904

231.4404 USD

Purchase

1,943

231.3013 USD

Purchase

3,065

231.2989 USD

Purchase

3,514

232.8533 USD

Purchase

3,667

233.0090 USD

Purchase

4,459

231.5073 USD

Purchase

7,631

231.3036 USD

Purchase

8,201

232.2332 USD

Purchase

8,512

232.2483 USD

Purchase

12,390

231.4430 USD

Purchase

12,495

231.3000 USD

Purchase

34,345

232.7487 USD

Purchase

35,149

232.4947 USD

Sale

1

231.3300 USD

Sale

1

232.8400 USD

Sale

2

231.1450 USD

Sale

37

232.5181 USD

Sale

60

231.4850 USD

Sale

100

234.0900 USD

Sale

100

234.1700 USD

Sale

100

233.9000 USD

Sale

100

233.8600 USD

Sale

108

232.3315 USD

Sale

145

231.2300 USD

Sale

160

233.4637 USD

Sale

400

232.1780 USD

Sale

824

232.1489 USD

Sale

1,267

232.5279 USD

Sale

1,267

232.5280 USD

Sale

1,397

232.4843 USD

Sale

3,214

232.9129 USD

Sale

3,700

232.6842 USD

Sale

4,177

233.2064 USD

Sale

4,574

231.6432 USD

Sale

4,667

232.7525 USD

Sale

7,342

232.2207 USD

Sale

7,729

231.3035 USD

Sale

17,334

231.3000 USD

Sale

20,000

231.4596 USD

Sale

33,971

232.3823 USD

Sale

34,345

232.7486 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

27 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210427005719/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87